Filters
Other countries
Results: 1 to 14 of 14
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
DLX3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Amelogenesis and Dentinogenesis Imperfecta Panel PreventionGenetics, part of Exact Sciences United States | 28 | 34 |
|
Amelogenesis Imperfecta via the DLX3 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Amelogenesis imperfecta and dentinogenesis imperfecta panel. NGS panel of 15 genes. Genologica Medica Spain | 22 | 14 |
|
Osteoporosis and bone dysplasia panel. 25-gene NGS panel. Genologica Medica Spain | 56 | 25 |
|
Amelogenesis imperfecta: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 18 | 17 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 135 | 136 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 543 | 178 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Genome Diagnostics Laboratory University Medical Center Utrecht Netherlands | 10 | 8 |
|
Amelogenesis Imperfecta NGS Panel Fulgent Genetics United States | 75 | 31 |
|
Amelogenesis Imperfecta, Type IV Dental Research Laboratory University of Michigan School of Dentistry United States | 1 | 1 |
|
Results: 1 to 14 of 14
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.